• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Populations and Evolution: Identifying the genetic basis of antigenic change in influenza A(H1N1)

tetano

Editor, Senior Moderator
Identifying the genetic basis of antigenic change in influenza A(H1N1)
William T. Harvey, Victoria Gregory, Donald J. Benton, James P. J. Hall, Rodney S. Daniels, Trevor Bedford, Daniel T. Haydon, Alan J. Hay, John W. McCauley, Richard Reeve
(Submitted on 16 Apr 2014)

Determining phenotype from genetic data is a fundamental challenge for virus research. Identification of emerging antigenic variants among circulating influenza viruses is critical to the vaccine virus selection process, with effectiveness maximized when vaccine constituents are antigenically matched to circulating viruses. Generally, antigenic similarity of viruses is assessed by the haemagglutination inhibition (HI) assay. We present models that define key antigenic determinants by identifying substitutions that significantly affect antigenic phenotype assessed using HI assay. Sequences of 506 haemagglutinin (HA) proteins from seasonal influenza A(H1N1) isolates and reference viruses, spanning over a decade, with complementary HI data and a crystallographic structure were analysed. We identified substitutions at fifteen surface-exposed positions as causing changes in antigenic phenotype of HA. At four positions the antigenic impact of substitutions was apparent at multiple points in the phylogeny, while eleven further sites were resolved by identifying branches containing antigenicity-changing events and determining the substitutions responsible by ancestral state reconstruction. Reverse genetics was used to demonstrate the causal effect on antigenicity of a subset of substitutions including one instance where multiple contemporaneous substitutions made a definitive identification impossible $\textit{in silico}$. This technique quantifies the impact of specific amino acid substitutions allowing us to make predictions of antigenic distance, increasing the value of new genetic sequence data for monitoring antigenic drift and phenotypic evolution. It demonstrates the generality of an approach originally developed for foot-and-mouth disease virus that could be extended to other established and emerging influenza virus subtypes as well as other antigenically variable pathogens.

Subjects: Populations and Evolution (q-bio.PE); Quantitative Methods (q-bio.QM)
Cite as: arXiv:1404.4197 [q-bio.PE]
(or arXiv:1404.4197v1 [q-bio.PE] for this version)

http://arxiv.org/abs/1404.4197
 
Back
Top Bottom